Font Size: a A A
Keyword [endpoint]
Result: 21 - 40 | Page: 2 of 5
21. Prognostic Value Of Plasma Fibrinogen In Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention
22. The Comparison Of Combination Test Approach And Modified Test Approach In Seamless Phase â…¡/â…¢ Trial
23. Clinical Study On Clinical Outcomes Of Shexiang Baoxin Pill In The Treatment Of Chronic Ttable Coronary Artery Disease
24. Evidence-based Pharmacotherapy Of Intervention With Rennin-angiotensin System Inhibitors To Prevent Clinical Endpoints In Hypertensive Patients
25. A Cohort Study On Preparations Of Nourishing Yin To Restrain Fire And Relieve Uneasiness Usage In 386 Cases Of Coronary Arrhythmia
26. Cohort Study Endpoint Hospital Of 313 Cases During The Follow-up Of Patients With Coronary Heart Arrhythmia Condition
27. The Predictive Value Of Serum Prebeta-1 High Density Lipoprotein On The Prognosis Of Patients With Coronary Heart Disease
28. Clinical Analysis On Prognosis Of Patients With Muiti-vessel Lesion Of Acute Coronary Syndrome In The Real Word Life
29. Multi-modal Medical Imaging Methods In Assessment And Prediction Of Uterine Artery Embolization For Fibroids
30. The Research Of Testing Criterion In Targeted Regions Based On MRCT Of Superiority Design About Survival Endpoint
31. Research On Ballistocardiogram Signal Extraction Method Based On Empirical Mode Decomposition
32. Association Of RDW With Severity Of Coronary Artery Disease And Cardiovascular Endpoint Event After PCI
33. The Study Of Left Atrial Pressure Measurement To Guide The Endpoint Of PBMV Expansion In The Case Of Right Ventricular Pacing
34. Inactivated Enterovirus 71 Vaccine:The Analysis Of Immunological Surrogate Endpoint
35. The Relationship Between The Fascicular Ventricular Tachycardia Ablation Strategy And The Endpoint And Its Long-term Follow-up Success Rate
36. Toward A More Sensitive Endpoint For Assessing Postoperative Complications In Patients With Inflammatory Bowel Disease:A Comparison Between Comprehensive Complication Index(CCI) And Clavien-Dindo Classification(CDC)
37. Statistical Methods For Survival Data By Incorporating Short-term Outcome And Its Application In Seamless Phase Ⅱ/Ⅲ Design
38. Surrogate Endpoints In Diffuse Large B-cell Lymphoma In The Rituximab Immunochemotherapy Era
39. Characteristics Of Different TCM Syndromes And TCM Constitutions In Ischemic Stroke And Their Correlation With Composite Endpoint Events
40. The Study Of The Consequences Of Mistakenly Adjusting For Mediators And Confounding Paradox In The Causal Effect Estimation
  <<First  <Prev  Next>  Last>>  Jump to